{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:15:00Z","timestamp":1778832900466,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"am","delay-in-days":418,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03 AG073985"],"award-info":[{"award-number":["R03 AG073985"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00CA237744"],"award-info":[{"award-number":["R00CA237744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jgo.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:11:09Z","timestamp":1668103869000},"page":"101403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia"],"prefix":"10.1016","volume":"14","author":[{"given":"Dharmini","family":"Manogna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi J.","family":"Lipof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassil","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason H.","family":"Mendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar S.","family":"Aljitawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen M.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Huselton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Burack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L.","family":"Liesveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2022.11.002_bb0005","series-title":"Cancer stat facts: leukemia - acute myeloid leukemia (AML)","year":"2021"},{"issue":"14","key":"10.1016\/j.jgo.2022.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.162.14.1597","article-title":"The outcomes and costs of acute myeloid leukemia among the elderly","volume":"162","author":"Menzin","year":"2002","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.jgo.2022.11.002_bb0015","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jgo.2022.11.002_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2141.2006.06403.x","article-title":"Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial","volume":"136","author":"van der Holt","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jgo.2022.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","article-title":"The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial","volume":"98","author":"Grimwade","year":"2001","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.jgo.2022.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jamaoncol.2017.2714","article-title":"Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality","volume":"3","author":"Sorror","year":"2017","journal-title":"JAMA Oncol"},{"issue":"29","key":"10.1016\/j.jgo.2022.11.002_bb0035","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.11.002_bb0040","first-page":"12","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how? Review","author":"Loke","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jgo.2022.11.002_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood."},{"issue":"15","key":"10.1016\/j.jgo.2022.11.002_bb0050","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","article-title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"4","author":"Sekeres","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jgo.2022.11.002_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00432-015-2045-8","article-title":"Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)","volume":"142","author":"Kahl","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.jgo.2022.11.002_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/blood-2018-99-118471","article-title":"Allogeneic hematopoietic stem cell transplantation improves outcome of elderly patients with acute myeloid leukemia in first complete remission: a time-dependent and multistate analysis from the French innovative leukemia organization","volume":"132","author":"Devillier","year":"2018","journal-title":"Blood."},{"issue":"17","key":"10.1016\/j.jgo.2022.11.002_bb0065","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"Jama."},{"issue":"2","key":"10.1016\/j.jgo.2022.11.002_bb0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/leu.2013.176","article-title":"Declining rates of treatment-related mortality in patients with newly diagnosed AML given \u2018intense\u2019 induction regimens: a report from SWOG and MD Anderson","volume":"28","author":"Othus","year":"2014","journal-title":"Leukemia."},{"issue":"15","key":"10.1016\/j.jgo.2022.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.18.01600","article-title":"Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib\/II study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2022.11.002_bb0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.jgo.2022.11.002_bb0085","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with Ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jgo.2022.11.002_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41409-021-01476-7","article-title":"Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60","volume":"57","author":"Pollyea","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jgo.2022.11.002_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2019.03.004","article-title":"Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: a single center experience of 355 consecutive patients","volume":"80","author":"Hilberink","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.jgo.2022.11.002_bb0100","series-title":"Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides","author":"Phelan","year":"2020"},{"issue":"7","key":"10.1016\/j.jgo.2022.11.002_bb0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbmt.2017.03.020","article-title":"Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes","volume":"23","author":"Getta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jgo.2022.11.002_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jgo.2022.11.002_bb0115","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1038\/s41375-020-0806-0","article-title":"Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia","volume":"34","author":"Herold","year":"2020","journal-title":"Leukemia."},{"issue":"12","key":"10.1016\/j.jgo.2022.11.002_bb0120","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1016\/j.jgo.2022.11.002_bb0125","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1200\/JCO.19.02809","article-title":"Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review","volume":"38","author":"DuMontier","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2022.11.002_bb0130","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/bloodadvances.2020001719","article-title":"Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes","volume":"4","author":"Olin","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jgo.2022.11.002_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41409-017-0021-4","article-title":"Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis","volume":"53","author":"Deschler","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jgo.2022.11.002_bb0140","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.jgo.2022.11.002_bb0145","doi-asserted-by":"crossref","first-page":"498.e1","DOI":"10.1016\/j.jtct.2022.05.018","article-title":"Geriatric assessment reveals actionable impairments in hematopoietic stem cell transplantation candidates age 18 to 80 years","volume":"28","author":"Lew","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"23","key":"10.1016\/j.jgo.2022.11.002_bb0150","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.2020005498","article-title":"Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia","volume":"136","author":"Saad","year":"2020","journal-title":"Blood."},{"issue":"21","key":"10.1016\/j.jgo.2022.11.002_bb0155","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood."},{"issue":"22","key":"10.1016\/j.jgo.2022.11.002_bb0160","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jgo.2022.11.002_bb0165","author":"Blood and Marrow Transplant Clinical Trials Network"},{"issue":"1","key":"10.1016\/j.jgo.2022.11.002_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jgo.2022.11.002_bb0175","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/bjc.2013.204","article-title":"Are the UK oncology trainees adequately informed about the needs of older people with cancer?","volume":"108","author":"Kalsi","year":"2013","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.jgo.2022.11.002_bb0180","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1200\/JOP.2017.022111","article-title":"Hematology-oncology fellows\u2019 training in geriatrics and geriatric oncology: findings from an American Society of Clinical oncology-sponsored national survey","volume":"13","author":"Maggiore","year":"2017","journal-title":"J Oncol Pract"},{"issue":"11","key":"10.1016\/j.jgo.2022.11.002_bb0185","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S1470-2045(21)00494-0","article-title":"Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial","volume":"22","author":"DiNardo","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2022.11.002_bb0190","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1038\/s41375-021-01229-x","article-title":"Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant","volume":"35","author":"DiNardo","year":"2021","journal-title":"Leukemia."}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822005227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822005227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:02:08Z","timestamp":1778832128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406822005227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1879406822005227"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2022.11.002","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101403"}}